We invite abstracts for the 34th Australasian Brachytherapy Group Annual Scientific Meeting 2026.

We are seeking exciting, innovative and creative presentations on all aspects of brachytherapy. Submissions are open to all professional streams and levels of experience within the field.

Abstract Categories

Submit your abstract under one of the following categories:

• Original Research - Present your team’s research outcomes, clinical studies, or new findings.
• Case Study/Series - Share interesting or complex clinical cases, unusual presentations, or learning experiences from patient care or dosimetric challenges.

Presentation Types

Oral presentations will be prioritised. However, if more abstract submissions are received than presentation slots available in the scientific program, the remaining abstracts will be selected for poster presentation.

Registration

All presenting authors (oral and poster) must register and pay to attend the Meeting. Please register by 19th November 2025 if your abstract is accepted.

Submission Notification

Acknowledgement of receipt of all abstract submissions will be made by email. Notification of abstract acceptance will be sent from the organisers on behalf of the Committee via email.

Word Counts and Limits

Biography of presenting author – limited to 100 words.

Abstract title – limited to 25 words.

Abstract text – limited to 400 words including acknowledgements.

Images – maximum file size of each image is 500 KB. The maximum pixel size of the graph/image is 600(w) x 800(h) pixel. 
You may upload images in JPG, GIF or PNG format.

Original Research Abstract Requirements

Original Research abstracts require specific headings and should clearly state:

• Background
• Aims
• Methods
• Results
• Conclusion

Case Study/Series Abstract Requirements

Case Study/Series abstracts are free-form and do not require specific headings. They should however describe the following:

• Presenting history
• Brachytherapy implant technique
• Applicator type
• Planning & optimisation methods
• Final dosimetry
• Clinical outcomes if available
• Clinical reasoning/decision-making for the above
• Challenges/learning experiences/what you would do differently next time

Guidelines for Submission

• Word counts and limits must be adhered to. 
• Submissions must be made in English. 
• The presenting author agrees to register for the conference no later than 19 November 2025.
• Use only standard abbreviations. Place special or unusual abbreviations in parentheses after the full word the first time it appears.
• Use generic names of drugs. The presentation must be balanced and contain no commercial promotional content.
• Submissions may not contain patient names, hospital ID numbers or other identifying information.

Selection Criteria

Abstract selection will be based on clarity, scientific rigor, significance, relevance, interest in the topic chosen, innovation and usefulness. The Committee has the right to refuse or accept any submission, accept the submission as a poster or an oral presentation and allocate the paper to a different category than the one under which it was submitted.